<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F"><gtr:id>FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F</gtr:id><gtr:name>Northwestern University</gtr:name><gtr:address><gtr:line1>633 Clark Street</gtr:line1><gtr:postCode>60208</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/368A4D3E-D7D0-4332-9510-83ED6685F1CE"><gtr:id>368A4D3E-D7D0-4332-9510-83ED6685F1CE</gtr:id><gtr:name>LFB Group</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F"><gtr:id>FE1EC3EB-3D38-4ABB-94B2-8429AC475C8F</gtr:id><gtr:name>Northwestern University</gtr:name><gtr:address><gtr:line1>633 Clark Street</gtr:line1><gtr:postCode>60208</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/368A4D3E-D7D0-4332-9510-83ED6685F1CE"><gtr:id>368A4D3E-D7D0-4332-9510-83ED6685F1CE</gtr:id><gtr:name>LFB Group</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2D704B38-D492-49B5-BE00-2D48D604ACA4"><gtr:id>2D704B38-D492-49B5-BE00-2D48D604ACA4</gtr:id><gtr:firstName>Anna</gtr:firstName><gtr:otherNames>Maria</gtr:otherNames><gtr:surname>Randi</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9FEF5688-07DC-4D73-9E0D-3F3335183096"><gtr:id>9FEF5688-07DC-4D73-9E0D-3F3335183096</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>A</gtr:otherNames><gtr:surname>Laffan</gtr:surname><gtr:orcidId>0000-0002-8268-3268</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600868"><gtr:id>B0163A73-B914-4CC1-8C2D-E74957C7AF23</gtr:id><gtr:title>&amp;quot;VON WILLEBRAND DISEASE AND ANGIODYSPLASIA: THE ROLE OF VON WILLEBRAND FACTOR IN VESSEL FORMATION&amp;quot;</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600868</gtr:grantReference><gtr:abstractText>Repair and formation of new blood vessels is a central process in health and disease. We propose that von willebrand factor, a blood protein made in the lining of blood vessels, plays an important role in regulating this process. Production of von willebrand factor is extremely variable in the population and thus may be an important contributor to disease. We have preliminary evidence that this can be observed and investigated using cells isolated from routine blood samples.</gtr:abstractText><gtr:technicalSummary>Von Willebrand disease (VWD), the most common congenital bleeding disorder is caused by a qualitative or quantitative deficiency of Von Willebrand factor (VWF), a multimeric plasma glycoprotein required for platelet adhesion to the sub-endothelium. VWF synthesized by endothelial cells (EC) is constitutively secreted or released from storage organelles, called Weibel-Palade bodies (WPB), in response to activation. VWF is required for the assembly of WPB, which contain several proteins including the endothelial growth factor Angiopoietin (Ang)-2. An association exists between VWF and angiodysplasia; a degenerative lesion of blood vessels and the most common cause for ?obscure? gastrointestinal blood loss. We suggest that vWF may be involved in angiogenesis, both directly via interaction with endothelial cells, and indirectly by contributing to platelet adhesion and by driving WPB assembly and storage of Ang-2. As a consequence, VWF may play a role in the pathogenesis of angiodysplasia. To test this hypothesis, we established a novel approach, using blood-derived endothelial progenitor cells (EPC). The preliminary data for this proposal shows that we have isolated EPC from normals and a patient with Type 1 VWD and angiodysplasia. VWF production by the patients? cells is significantly reduced. EPC from the VWD patient showed increased tube formation in an in vitro angiogenesis assay (Matrigel assay), compared to control. These data are consistent with the hypothesis that decreased levels of endothelial VWF result in an increased ability to form tubes in vitro and angiodysplasia in vivo. Aims of this proposal are: to investigate the role of VWF in angiogenesis using blood-derived EPC and human umbilical vein endothelial cells (HUVEC), and to demonstrate that blood-derived EPC from patients are an essential tool to investigate the molecular basis of endothelial defects. The experiments delineated here are divided into 3 sections: the first part includes in vitro studies on HUVEC to determine the role of vWF in angiogenesis, by means of siRNA, blocking antibodies and recombinant fragments. The second part focuses on the study of EPC from patients with vWD and angiodysplasia, to characterise their endothelial function, particularly related to angiogenesis. The final part of the proposal focuses on the molecular mechanisms which link vWF, the assembly of WPB and Ang-2. These experiments will establish a new mechanism of regulation of angiogenesis, and a new function for the adhesion molecule vWF. Moreover, the use of EPCs represents a novel approach in the study of primary endothelial defects, applicable to many other diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2010-06-24</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-06-25</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>393401</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>endothelial recycling and angiogenesis</gtr:description><gtr:id>C33E3908-BA55-473F-A546-EE548358FFCE</gtr:id><gtr:impact>One paper in Blood, one BHF Intermediate Research fellowship for Richard Starke (postdoc on the MRC grant)</gtr:impact><gtr:outcomeId>87AE5C867E0-1</gtr:outcomeId><gtr:partnerContribution>intellectual input, experiments, data analysis</gtr:partnerContribution><gtr:piContribution>we have been driving the project focussing on the cell biology, in vivo and translational aspects of the research</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Northwestern University Chicago</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>VWF bindign to growth factors</gtr:description><gtr:id>16B82E5E-E4EE-4268-9804-CCA72A586821</gtr:id><gtr:impact>paper in preparation</gtr:impact><gtr:outcomeId>56d81ced45c950.45933890-1</gtr:outcomeId><gtr:partnerContribution>They have provided unique models and their expertise in the field of matrix - growth factor interactions</gtr:partnerContribution><gtr:piContribution>we are leading the collaboration with Prf. Hubbell. We have contributed the original idea, some of teh key reagents and experimental models</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>LFB Group</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>use of high purity VWF in angiogenesis assays</gtr:description><gtr:id>F08CE080-B450-4A87-B293-5ACFE3681C43</gtr:id><gtr:impact>ongoing. Predicted outcomes are publications; research funding; possible IP</gtr:impact><gtr:outcomeId>56d8305ed82c53.41125198-1</gtr:outcomeId><gtr:partnerContribution>provided reagents; non-restricted research grant; invitation to conferences;</gtr:partnerContribution><gtr:piContribution>test the effect of high [purity VWF (Wilfactin) on endothelial cell function in angiogenesis in vitro</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Heart &amp; Lung Institute (NHLI)</gtr:department><gtr:description>VWF and retina angiogenesis</gtr:description><gtr:id>0A7C39D1-66BD-475E-8DDE-228A9B13EED7</gtr:id><gtr:impact>One Publication; two clinical studies to be started in 2011</gtr:impact><gtr:outcomeId>MkWJrVBjC6R-1</gtr:outcomeId><gtr:partnerContribution>The collaborator Prof. Alun Hughes has carried out the analysis of mouse retina in VWF KO mice, using an in-house generated software</gtr:partnerContribution><gtr:piContribution>We generated the hypothesis and teh supportign data, and provided the VWF KO mice for the analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>St George's University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>capillaroscopy</gtr:description><gtr:id>4DD531A0-0D3C-4290-B259-272788FF49F1</gtr:id><gtr:impact>just started - in the process of applyign for funding</gtr:impact><gtr:outcomeId>5464966f3dd0c4.57547115-1</gtr:outcomeId><gtr:partnerContribution>Dr Antonios at George's has developed a technique which allows to visualize capillarised in patients neil bed and sublingual.</gtr:partnerContribution><gtr:piContribution>we have found that the plasma protein VWF controls blood vessel formation. This has implication for a number of diseases. The ability to visualize blood vessles morp[hology in patients would improve treatment and management. Patients include congenital VWD (prevalence 1% of teh populaiton) , heart failure patients with LVAD, and otehr patients with acquired VWD</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>hind limb ischemia VWF</gtr:description><gtr:id>97E08D35-C787-498C-A646-CD994E0B1A2B</gtr:id><gtr:impact>publication in preparation; presentation at ISTH 2013</gtr:impact><gtr:outcomeId>5464984c362849.59373176-1</gtr:outcomeId><gtr:partnerContribution>Dr Lisa Deindl's group has carried out in vivo experiments on VWF KO mice and identify novel important in vivo phenotypes, which are currently being incorporated in a manuscript in preparation</gtr:partnerContribution><gtr:piContribution>we have discovered that deficiency of VWF in mouse results in increased angiogenesis. We set up this collaboration to investigate the implicaitons of thsi finding in models of ischemia</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>318313</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The role of von Willebrand factor in angiogenesis.</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>F86EFE4B-CA01-4F5A-99E3-12F36DF9C0B5</gtr:id><gtr:outcomeId>PAEqcNDdwpz0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>we have developed novel techniques to image the vascualture in the mouse ear, which allows 3D reconstruction and quantification.</gtr:description><gtr:id>6F7F19C1-E0CA-4984-9BA3-717783CDDD1A</gtr:id><gtr:impact>This technique allows visualization of the vascular tree in tissue. We are now colaborating with colleagues at Imperial to apply this approach to human samples and use mathematical modelling to predict blood flow and oxigen exchange in these structures</gtr:impact><gtr:outcomeId>FAD7CD9F165</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>in vivo imaging of blood vessels</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have established an assay to isolate and expand endothelial cells from patients' blood, in order to study endothelial defects in humans. These cells can be isolated from 30-50 ml blood</gtr:description><gtr:id>F0B4C4A3-14F9-4BA2-AC93-AF748B1C8717</gtr:id><gtr:impact>This is a powerful translational tool which we have appleid to two disease areas so far (Von Willebrand Disease and COPD) and are planning to extend to other diseases in the haematological and cardiovascular fields.</gtr:impact><gtr:outcomeId>62F3EE1BFCF</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Endothelial progenitor cells isolation from human blood</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have improved the method of isolation of mouse endothelial cells from various tissues, prevalently lung, with increased cell purity and yield.</gtr:description><gtr:id>09BD0C5F-3E54-4325-856F-9AED19502235</gtr:id><gtr:impact>This technique is applicable for the isolation of endothelial cells from any mouse model, and therefore represents an extremely important tool for the study of vascular diseases</gtr:impact><gtr:outcomeId>039F4A3B8C7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>isolation of mouse lung endothelial cells</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>22C7FDB8-ECB3-4607-BF7D-D8849CF6FFEC</gtr:id><gtr:title>Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8bb7e7cfa63685603144fb95af08830"><gtr:id>f8bb7e7cfa63685603144fb95af08830</gtr:id><gtr:otherNames>Starke RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_15745_25_23355534</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2E946CB-ED6A-4768-98E2-62C8779F7908</gtr:id><gtr:title>Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa1f1eebde797c889a9034233adf15fa"><gtr:id>aa1f1eebde797c889a9034233adf15fa</gtr:id><gtr:otherNames>Paschalaki KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_15745_25_23897750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59E6EDC5-11E1-4A58-BE49-A66A02E45C8B</gtr:id><gtr:title>Endothelial Von Willebrand factor regulates angiogenesis</gtr:title><gtr:parentPublicationTitle>Vascular Pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/089e3bc46fae61ff007634fb3ada86ec"><gtr:id>089e3bc46fae61ff007634fb3ada86ec</gtr:id><gtr:otherNames>Starke R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1537-1891</gtr:issn><gtr:outcomeId>56dd6cb2c46e93.60484894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21266DF4-0076-460A-8E82-DCD8834F0064</gtr:id><gtr:title>Endothelial dysfunction in von Willebrand disease: angiogenesis and angiodysplasia.</gtr:title><gtr:parentPublicationTitle>Thrombosis research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5b91425004a20e7038bcf54b87f7ea3"><gtr:id>a5b91425004a20e7038bcf54b87f7ea3</gtr:id><gtr:otherNames>Randi AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0049-3848</gtr:issn><gtr:outcomeId>585d64b1b47473.04005233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3CC6F21-B821-40C3-A0DF-5AB4E1B0F1AC</gtr:id><gtr:title>Von Willebrand factor and angiogenesis: basic and applied issues.</gtr:title><gtr:parentPublicationTitle>Journal of thrombosis and haemostasis : JTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5b91425004a20e7038bcf54b87f7ea3"><gtr:id>a5b91425004a20e7038bcf54b87f7ea3</gtr:id><gtr:otherNames>Randi AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1538-7836</gtr:issn><gtr:outcomeId>5aa669a4825f00.39933021</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A85C0792-5AB1-4EE5-840E-EAC5757BC9AE</gtr:id><gtr:title>An autologous endothelial cell:peripheral blood mononuclear cell assay that detects cytokine storm responses to biologics.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6876405508e7bf34fb809ea1df37d15"><gtr:id>c6876405508e7bf34fb809ea1df37d15</gtr:id><gtr:otherNames>Reed DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>56d835c1825580.14281501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77FB47E2-FD35-4852-82E7-BF63EF228223</gtr:id><gtr:title>Von Willebrand factor, angiodysplasia and angiogenesis.</gtr:title><gtr:parentPublicationTitle>Mediterranean journal of hematology and infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a5b91425004a20e7038bcf54b87f7ea3"><gtr:id>a5b91425004a20e7038bcf54b87f7ea3</gtr:id><gtr:otherNames>Randi AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2035-3006</gtr:issn><gtr:outcomeId>pm_15745_25_24106610</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D07F8D11-F061-4B15-8A0C-712E375E2E68</gtr:id><gtr:title>Cellular and molecular basis of Von Willebrand disease: Studies on blood outgrowth endothelial cells</gtr:title><gtr:parentPublicationTitle>Atherosclerosis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/089e3bc46fae61ff007634fb3ada86ec"><gtr:id>089e3bc46fae61ff007634fb3ada86ec</gtr:id><gtr:otherNames>Starke R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>5a6ef18604fac5.43285822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>976B89C2-C6A0-4FB7-AECF-53EB95657D7B</gtr:id><gtr:title>Endothelial von Willebrand factor regulates angiogenesis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8bb7e7cfa63685603144fb95af08830"><gtr:id>f8bb7e7cfa63685603144fb95af08830</gtr:id><gtr:otherNames>Starke RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>Pzpe5vHzFHY</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600868</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>